Primary tabs
Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.
| Revision | Operations | |
|---|---|---|
| 02-7-25 by ripal121 ripal121 replaced Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module. | current revision | |
| 02-7-25 by ripal121 ripal121 replaced Intermittent HD with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module. | ||
| 02-7-25 by conan.macdougal... [email protected] replaced For detailed view of dialysis dosing and evidence, see <a href="https://idmp.ucsfsitebuilder.acsitefactory.com/content/ucsf-adult-antimicrobial-dosing-dialysis-reference-document">Dosing in Hemodialysis</a> document.</p> with via Scanner Search and Replace module. | ||
| 11-18-24 by kaipe | ||
| 11-4-24 by [email protected] | ||
| 07-31-24 by kaipe | ||
| 10-25-23 by kaipe Updated unrestricted indications to include high-risk kidney transplant recipients and continuation of outpatient therapy | ||
| 08-31-23 by ripal121 | ||
| 07-20-23 by ripal121 | ||
| 02-17-22 by [email protected] | ||
| 08-13-20 by conan.macdougal... | ||
Dosing: Adult Antimicrobial Dosing, Non-dialysis
| Indication | CrCl >10 mL/min | <10 mL/min |
|---|---|---|
| All Indications |
480 mg IV/PO q24h With concomitant cyclosoprine: 240 mg IV/PO q24h |
No dosing recommendations available |
ZSFG: Non-formulary
Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis
| Indication | Dosing | Notes |
|---|---|---|
| All Indications |
480 mg IV/PO q24h With concomitant cyclosoprine: 240 mg IV/PO q24h |
No dosing recommendations available for hemodialysis |
ZSFG: Non-formulary
Dialysis Notes
Restricted to ID or Antimicrobial Stewardship except for:
1) Adult malignant hematology service - for prophylaxis only per service guidelines
2) Prophylaxis of CMV disease in high-risk kidney transplant recipients
3) Continuation of current outpatient therapy
ZSFG: Non-formulary